GW501516 is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s. From Wikipedia
Athletics Integrity Unit disqualifies all results since July 2023, rejecting claims of contamination from recovery gummies.
